Cambridge joins vaccine race, aims for autumn trials, Health News, ET HealthWorld

SaveSavedRemoved 0
Deal Score0
Deal Score0

Cambridge joins vaccine race, aims for autumn trialsLondon: Cambridge is aiming to start clinical trials of its possible Covid vaccine in the autumn after it received 1.9 million in funding from the British government, the university said on Wednesday. The candidate, DIOS-CoVax2, is DNA based. Computer-generated antigen structures are encoded by synthetic genes, which can then re-programme the body’s immune system to produce antibodies against the coronavirus.

Russia readies for approval of second Covid-19 vaccine
Russia is preparing to approve a second vaccine as early as September-end, Russian deputy PM Golikova said. Earlier this month, it became the first country to approve a vaccine despite inadequate testing. Agencies

Follow and connect with us on , Facebook, Linkedin

Source link

We will be happy to hear your thoughts

Leave a reply